Syntheses and In Vitro antitumor activity of 3-amino-N-(4- chlorobenzenesulfonyl)guanidine derivatives containing N′-arylidene moiety

Polish Journal of Chemistry

Volumn 78, Issue 3, 2004, Pages 369-379

  Slawinski J ^a   Bednarski, P ^b   Reszka, P ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

3 amino N (benzenesulfonyl)guanidines; Anticancer activity; Synthesis

Indexed keywords

1 (2 BENZYLTHIO 4 CHLORO 5 METHYLBENZENESULFONYL) 3 (5 NITROFURFURYLIDENEAMINO)GUANIDINE; 1 (2 BENZYLTHIO 4 CHLORO 5 METHYLBENZENESULFONYL) 3 (5 NITROTHIENYLIDENEAMINO)GUANIDINE; 1 (4 CHLORO 2 ETHOXYCARBONYLMETHYLTHIO 5 METHYLBENZENESULFONYL) 3 (5 NITROFURFURYLIDENEAMINO)GUANIDINE; 1 (4 CHLORO 2 ETHOXYCARBONYLMETHYLTHIO 5 METHYLBENZENESULFONYL) 3 (5 NITROTHIENYLIDENEAMINO)GUANIDINE; 1 (4 CHLORO 2 ETHYLTHIO 5 METHYLBENZENESULFONYL) 3 (5 NITROTHIENYLDENEAMINO)GUANIDINE; 1 BENZYLIDENE 2 (2 BENZYLTHIO 4 CHLORO 5 METHYLBENZENESULFONYL) 3 METHYLAMINOGUANIDINE; 1 BENZYLIDENE 2 (4 CHLORO 2 ETHYLTHIO 5 METHYLBENZENESULFONYL) 3 METHYLAMINOGUANIDINE; 2 (2 BENZYLTHIO 4 CHLORO 5 METHYLBENZENESULFONYL) 3 METHYLAMINO 1 (5 NITROFURFURYLIDENE)GUANIDINE; 2 (2 BENZYLTHIO 4 CHLORO 5 METHYLBENZENESULFONYL) 3 METHYLAMINO 1 (5 NITROTHIENYLIDENE)GUANIDINE; 2 (4 CHLORO 2 ETHOXYCARBONYLMETHYLTHIO 5 METHYLBENZENESULFONYL) 3 METHYLAMINO 1 (5 NITROFURFURYLIDENE)GUANIDINE; 2 (4 CHLORO 2 ETHOXYCARBONYLMETHYLTHIO 5 METHYLBENZENESULFONYL) 3 METHYLAMINO 1 (5 NITROTHIENYLIDENE)GUANIDINE; 2 (4 CHLORO 2 ETHYLTHIO 5 METHYLBENZENESULFONYL) 3 METHYLAMINO 1 (5 NITROTHIENYLIDENE)GUANIDINE; 2 [2 BENZYLTHIO 4 CHLORO 5 (4 CHLOROPHENYLCARBAMOYL)BENZENESULFONYL] 3 METHYLAMINO 1 (5 NITROTHIENYLIDENE)GUANIDINE; 3 AMINO N (4 CHLOROBENZENESULFONYL)GUANIDINE; 3 BENZYLIDENEAMINO 1 (2 BENZYLTHIO 4 CHLORO 5 METHYLBENZENESULFONYL)GUANIDINE; 3 BENZYLIDENEAMINO 1 (4 CHLORO 2 ETHYLTHIO 5 METHYLBENZENESULFONYL)GUANIDINE; ALKENE DERIVATIVE; ANTINEOPLASTIC AGENT; GUANIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; EVALUATION; GERMANY; HUMAN; HUMAN CELL; IN VITRO STUDY;

EID: 17044448107     PISSN: 01375083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Casini A., Scozzafava A., Mastrolorenzo A. and Supuran C.T., Curr. Cancer Drug Targets, 2, 55 (2002).
2. Scozzafava A., Owa T., Mastrolorenzo A. and Supuran C.T., Curr. Med. Chem., 10, 925 (2003).
3. Scozzafava A., Casini A. and Supuran C.T., Curr. Med. Chem., 9, 1167 (2002).
4. Supuran C.T., Casini A. and Scozzafava A., Med. Res. Rev., 23, 535 (2003).
5. Artico M., Il Farmaco, 51, 305 (1996).
6. Leung D., Abbenante G. and Fairlie D., J. Med. Chem., 43, 305 (2000).
7. Vermeire K., Bell T.W., Choi H.J., Jin Q., Samala M.F., Sodoma A., de Clercq E. and Schols D., Mol. Pharmacol., 63, 203 (2003).
8. Chern J., Leu Y., Wang S., Jou R., Lee C., Tsou P., Hsu S., Liaw Y. and Lin H., J. Med. Chem., 40, 2276 (1997).
9. Pindur U. and Lemster T., Pharmazie, 53, 79 (1998).
10. Stanek J., Caravatti G., Capraro H-G., Furet P., Mett H., Schneider P. and Regenass U., J. Med. Chem., 36, 46 (1993).
11. Stanek J., Caravatti G., Frei J., Furet P., Mett H., Schneider P. and Regenass U., J. Med. Chem., 36, 2168 (1993).
12. Matsumo S., Myaguchi M., Ito A., Hara N. and Sakurada N., Jpn. Pat. 06, 192,215; C.A., 121, 300598t (1994).
13. Sławiński J., Bednarski P., Grünert R. and Reszka P., Polish J. Chem., 77, 53 (2003).
14. Brzozowski Z. and Sa̧czewski F., Eur. J. Med. Chem., 37, 285 (2002).
15. Bernhardt G., Reile H., Birnböck H., Spruß T. and Schönenberger H., J. Cancer Res. Clin. Oncol., 118, 35 (1992).
16. Details of this system and the information which is encoded by the activity pattern over all cell lines have been also described in our previous paper ref. [13].
17. Boyd M.R., Am. Assoc. Cancer Res., 30, 652 (1989).
18. Monks A.P., Scudiero D.A., Skehan P., Shoemaker K.D., Poull D., Vistica C., Hose C., Langley J., Cronise P., Vaigro-Wolff A., Gray-Goodrich M., Cambell H., Mayo M. and Boyd M., J. Natl. Cancer Inst., 83, 757 (1991).
19. Weinstein J.N., Myers T.G., O'Connor P.M., Friend S.H., Fornance A.J., Jr., Kohn K.W., Fojo T., Bates S.E., Rubinstein L.V., Anderson N.L., Buolamwini J.K., van Osdol W.W., Monks A.P., Scudiero D.A., Sausiville E.A., Zaharevitz D.W., Bunow B., Viswanadhan V.N., Johnson G.S., Wittes R.E. and Paull K.D., Science, 275, 343 (1997).
20. Sławiński J., Polish J. Chem., 75, 1309 (2001).